Company / SG&A per Share
Regeneron Pharmaceuticals SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$23.75
FY2025
5-year range
$11.69 / $26.03
FY2021-FY2025
Trend
-8.8%
vs FY2024
Sector context
#6 of 210
Health Care
What the data says
Among 210 Health Care companies, Regeneron Pharmaceuticals is in the bottom 3% for sg&a per share. SG&A per Share has fluctuated over the past 10 years, ranging from $9.69 in FY2018 to $26.03 in FY2024.
Based on SEC 10-K filings.
23.75 in FY2025 with a 5-year CAGR of +19.3%. Top quartile in the Health Care sector.
Remained stable around $23.75 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +26.6%
- 5-Year CAGR
- +19.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 210This company $23.75 Sector average $40.75
▼
-41.7% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 8.8% year-over-year.
- Ranks #6 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2024.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 3.03 (safe zone, above 2.9 threshold)
- Strong profit margin: 32.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.75 | -8.8% |
| FY2024 | $26.03 | +11.0% |
| FY2023 | $23.45 | +100.5% |
| FY2022 | $11.69 | -0.1% |
| FY2021 | $11.71 | +19.3% |
| FY2020 | $9.82 | -15.2% |
| FY2019 | $11.58 | +19.5% |
| FY2018 | $9.69 | -15.4% |
| FY2017 | $11.46 | +10.3% |
| FY2016 | $10.38 | +37.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026